Should all adult cystic fibrosis patients with repeated nontuberculous mycobacteria cultures receive specific treatment? A 10-year case-control study
Eur Respir J
.
2016 May;47(5):1575-7.
doi: 10.1183/13993003.01239-2015.
Epub 2016 Feb 4.
Authors
Christiane Albrecht
1
,
Felix Ringshausen
1
,
Sebastian Ott
2
,
Dirk Wagner
3
,
Jessica Rademacher
1
,
Michael Schneider
4
,
Tobias Welte
1
,
Mathias W Pletz
5
Affiliations
1
Dept of Pulmonary Medicine, Hannover Medical School, German Center for Lung Research (DZL), Hannover, Germany.
2
Dept of Pulmonary Medicine, University Hospital Bern (Inselspital) and University of Bern, Bern, Switzerland.
3
Dept of Infectious Diseases and Center for Chronic Immunodeficiency, University Medical Center, Freiburg, Germany.
4
Center for Biometry, Medical Informatics and Medical Technology, Hannover Medical School, Hannover, Germany.
5
Center for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany mathias.pletz@med.uni-jena.de.
PMID:
26846823
DOI:
10.1183/13993003.01239-2015
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Adult
Case-Control Studies
Cystic Fibrosis / microbiology*
Cystic Fibrosis / therapy*
Humans
Mycobacterium / isolation & purification*